Methoxamine Hydrochloride - CAS 61-16-5
Catalog number:
61-16-5
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C11H18ClNO3
Molecular Weight:
247.72
COA:
Inquire
Targets:
Adrenergic Receptor
Description:
Methoxamine Hydrochloride is an alpha-1 adrenergic agonist, similar in structure to butaxamine and 2,5-DMA. It causes prolonged peripheral vasoconstriction. It induces vasoconstriction of skin and splanchnic blood vessels, thus increasing peripheral vascular resistance and raising mean arterial blood pressure. lt is used for the treatment of paroxysmal supraventricular tachycardia and is used as a booster in the state of low blood pressure. It has been listed.
Publictions citing BOC Sciences Products
  • >> More
Purity:
98%
Appearance:
Solid powder
Synonyms:
1-(2,5-Dimethoxyphenyl)-2-aminopropanol;2-Amino-1-(2,5-dimethoxyphenyl)-1-propanolhydrochloride;Alpha-(1-aminoethyl)-2,5-dimethoxy-benzenemethano hydrochloride;Methoxamine HCl;Vasoxyl hydrochloride;2-Amino-1-(2,5-dimethoxyphenyl)propan-1-ol hydrochloride
Solubility:
Soluble in DMSO, not in water
Storage:
2-8°C
MSDS:
Inquire
Application:
Methoxamine Hydrochloride is used for the treatment of paroxysmal supraventricular tachycardia and is used as a booster in the state of low blood pressure.
Quality Standard:
In-house standard
Quantity:
Kilograms to Tons
Boiling Point:
368.4 °C at 760 mmHg
Melting Point:
212-216 °C
InChIKey:
YGRFXPCHZBRUKP-UHFFFAOYSA-N
InChI:
InChI=1S/C11H17NO3.ClH/c1-7(12)11(13)9-6-8(14-2)4-5-10(9)15-3;/h4-7,11,13H,12H2,1-3H3;1H
Canonical SMILES:
CC(C(C1=C(C=CC(=C1)OC)OC)O)N.Cl
Current Developer:
Methoxamine Hydrochloride has been listed.
1.Stimulation of calcium-sensing receptors induces endothelium-dependent vasorelaxations via nitric oxide production and activation of IKCa channels.
Greenberg HZ1, Shi J2, Jahan KS2, Martinucci MC2, Gilbert SJ2, Vanessa Ho WS2, Albert AP2. Vascul Pharmacol. 2016 May;80:75-84. doi: 10.1016/j.vph.2016.01.001. Epub 2016 Jan 6.
Stimulation of vascular calcium-sensing receptors (CaSRs) is reported to induce both constrictions and relaxations. However, cellular mechanisms involved in these responses remain unclear. The present study investigates the effect of stimulating CaSRs on vascular contractility and focuses on the role of the endothelium, nitric oxide (NO) and K(+) channels in these responses. In wire myography studies, increasing [Ca(2+)]o from 1mM to 6mM induced concentration-dependent relaxations of methoxamine pre-contracted rabbit mesenteric arteries. [Ca(2+)]o-induced relaxations were dependent on a functional endothelium, and were inhibited by the negative allosteric CaSR modulator Calhex-231. [Ca(2+)]o-induced relaxations were reduced by inhibitors of endothelial NO synthase, guanylate cyclase, and protein kinase G. CaSR activation also induced NO production in freshly isolated endothelial cells (ECs) in experiments using the fluorescent NO indicator DAF-FM.
2.Effects of tempol on altered metabolism and renal vascular responsiveness in fructose-fed rats.
Abdulla MH1, Sattar MA2, Johns EJ1. Appl Physiol Nutr Metab. 2016 Feb;41(2):210-8. doi: 10.1139/apnm-2015-0411. Epub 2015 Nov 5.
This study investigated the effect of tempol (a superoxide dismutase mimetic) on renal vasoconstrictor responses to angiotensin II (Ang II) and adrenergic agonists in fructose-fed Sprague-Dawley rats (a model of metabolic syndrome). Rats were fed 20% fructose in drinking water (F) for 8 weeks. One fructose-fed group received tempol (FT) at 1 mmol·L(-1) in drinking water for 8 weeks or as an infusion (1.5 mg·kg(-1)·min(-1)) intrarenally. At the end of the treatment regimen, the renal responses to noradrenaline, phenylephrine, methoxamine, and Ang II were determined. F rats exhibited hyperinsulinemia, hyperuricemia, hypertriglyceridemia, and hypertension. Tempol reduced blood glucose and insulin levels (all p < 0.05) in FT rats compared with their untreated counterparts. The vasoconstriction response to all agonists was lower in F rats than in control rats by about 35%-65% (all p < 0.05). Vasoconstrictor responses to noradrenaline, phenylephrine, and methoxamine but not Ang II were about 41%-75% higher in FT rats compared with F rats (all p < 0.
3.Pharmacological evidence that NaHS inhibits the vasopressor responses induced by stimulation of the preganglionic sympathetic outflow in pithed rats.
Centurión D1, De la Cruz SH2, Gutiérrez-Lara EJ2, Beltrán-Ornelas JH2, Sánchez-López A2. Eur J Pharmacol. 2016 Jan 5;770:40-5. doi: 10.1016/j.ejphar.2015.11.057. Epub 2015 Nov 28.
It has been reported that i.v. administration of NaHS, a donor of H2S, elicited dose-dependent hypotension although the mechanisms are not completely understood. In this regard, several mechanisms could be involved including the inhibition of the vasopressor sympathetic outflow. Thus, this study was designed to determine the potential capability of NaHS to mediate inhibition of the vasopressor responses induced by preganglionic sympathetic stimulation. For this purpose, Wistar rats were anaesthetised, pithed and cannulated for drug administration. In animals pre-treated with gallamine, the effect of i.v. infusion of NaHS (310 and 560μg/kgmin) or its vehicle (phosphate buffer) was determined on the vasopressor responses induced by: (1) sympathetic stimulation (0.03-10Hz); (2) i.v. bolus injections of exogenous noradrenaline (0.03-3μg/kg); or (3) methoxamine (1-100μg/kg). The vasopressor responses induced by preganglionic sympathetic stimulation were dose-dependently inhibited by i.
4.Endothelial nitric oxide weakens arterial contractile responses and reduces blood pressure during early postnatal development in rats.
Sofronova SI1, Borzykh AA2, Gaynullina DK3, Kuzmin IV4, Shvetsova AA4, Lukoshkova EV5, Tarasova OS4. Nitric Oxide. 2016 Feb 23;55-56:1-9. doi: 10.1016/j.niox.2016.02.005. [Epub ahead of print]
OBJECTIVE: During maturation the vascular system undergoes structural and functional remodeling. At the systemic level it results in a gradual increase of arterial blood pressure during postnatal ontogenesis. The mechanisms of maintaining the blood pressure at a comparatively low level during the early postnatal development are not completely understood. Recently we showed that the hindlimb arteries of young (1-2 wk-old) rats exhibited an enhanced endothelial NO-pathway activity, which weakened their contractile responsiveness compared to the arteries of adult rats. Here we tested the hypothesis that an increased tonic endothelial NO production can take place in the whole vascular system leading to a decreased level of systemic blood pressure in young rats.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Adrenergic Receptor Products


MK-0634 dihydrochloride
(CAS: 211031-81-1)

MK-0634, also called as L-796568, is an β3 adrenergic receptor agonist that was progressed into clinical studies for the treatment of obesity in the early 2000s...

CAS 19237-84-4 Prazosin Hydrochloride

Prazosin Hydrochloride
(CAS: 19237-84-4)

Prazosin HCl, a quinazoline derivative, is the first of a new chemical class of antihypertensives.

GYKI-16084
(CAS: 185739-21-3)

GYKI-16084 is a postsynaptic alpha2-blocker with the potential to treat benign prostatic hyperplasia.

CAS 27912-14-7 Levobunolol hydrochloride

Levobunolol hydrochloride
(CAS: 27912-14-7)

Levobunolol hydrochloride, a beta1- and beta2-adregergic blocking agent, has proved to be an effective ocular hypotensive agent to treat glaucoma.

CAS 13523-86-9 Pindolol

Pindolol
(CAS: 13523-86-9)

Pindolol, an Indole derivative, could be used in the treatment of hypertension and arrhythmia for acting as a 5-HT1A/1B receptor antagonist. IC50: 33nM(Ki).

CAS 29110-47-2 Guanfacine

Guanfacine
(CAS: 29110-47-2)

Guanfacine, a selective agonist of α2A receptor, is a sympatholytic drug to treat attention deficit hyperactivity disorder (ADHD) and hypertension. It lowers bo...

CAS 104054-27-5 Atipamezole

Atipamezole
(CAS: 104054-27-5)

Atipamezole, a 4-substituted imidazole derivative, is an alpha2-adrenoceptor blocker which could be used for animals to recover from the anesthesia by lowering ...

CAS 59-98-3 Tolazoline

Tolazoline
(CAS: 59-98-3)

Tolazoline is a non-selective competitive α-adrenergic receptor antagonist used in treatment of persistent pulmonary hypertension of the newborn..

CAS 34381-68-5 Acebutolol hydrochloride

Acebutolol hydrochloride
(CAS: 34381-68-5)

Acebutolol is a β-adrenergic receptors antagonist used in the treatment of hypertension, angina pectoris and cardiac arrhythmias.

CAS 77883-43-3 Doxazosin Mesylate

Doxazosin Mesylate
(CAS: 77883-43-3)

Doxazosin mesylate is an α1-selective alpha blocker used to treat high blood pressure and urinary retention associated with benign prostatic hyperplasia.

CAS 555-30-6 Methyldopa

Methyldopa
(CAS: 555-30-6)

Methyldopa (Aldomet) is a DOPA decarboxylase competitive inhibitor with an ED50 of 21.8 mg/kg.

CAS 65-28-1 Phentolamine Mesylate

Phentolamine Mesylate
(CAS: 65-28-1)

Phentolamine Mesylate is a nonselective alpha-adrenergic antagonist with IC50 of 0.1 μM.

CAS 81403-68-1 Alfuzosin HCl

Alfuzosin HCl
(CAS: 81403-68-1)

Alfuzosin HCl is an alpha1 receptor antagonist used to treat benign prostatic hyperplasia (BPH).

CAS 1491-59-4 Oxymetazoline

Oxymetazoline
(CAS: 1491-59-4)

Oxymetazoline, an imidazol derivative, has been found to be an adrenergic receptor agonist that could be an effective topical decongestant.

BMS-196085
(CAS: 170686-10-9)

BMS-196085, a sulfanilamide derivative, has been found to be a β-adrenergic receptor agonist that was once studied in obesity as well as yype 2 diabetes mellitu...

CAS 4205-91-8 Clonidine Hydrochloride

Clonidine Hydrochloride
(CAS: 4205-91-8)

Clonidine HCl is a direct-acting α2 adrenergic agonist with an ED50 of 0.02±0.01 mg/kg.

CAS 148274-76-4 MG 1

MG 1
(CAS: 148274-76-4)

An α1 adrenergic receptor antagonist

SNAP-8719 HCl
(CAS: 255893-38-0)

SNAP-8719, structurally very similar to BMY-7378, is a selective, orally active α1D-AR antagonist with lower binding affinity for the 5-HT1A receptor.

CAS 29110-48-3 Guanfacine HCl

Guanfacine HCl
(CAS: 29110-48-3)

Guanfacine HCl is the hydrochloride salt of Guanfacine. Guanfacine, a selective agonist of α2A receptor, is a sympatholytic drug to treat attention deficit hype...

CAS 73573-87-2 Formoterol

Formoterol
(CAS: 73573-87-2)

Formoterol is a Beta 2 adrenergic receptor agonist. It can be used in the treatment of asthma and COPD. It has an extended duration of action (up to 12 hours) c...

Chemical Structure

CAS 61-16-5 Methoxamine Hydrochloride

Quick Inquiry

Verification code

Featured Items